Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermacyd Infantile Compatibility Study
NCT00881374Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2009
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Dermacyd, sponsored by Sanofi. Primary endpoint: Absence of primary and accumulated dermic irritability and dermic sensitivity at 6 weeks. Started Feb 2009; status: completed.
02
Drugs
Dermacyd
Beyond the preview
Go deeper on NCT00881374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881374.